Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:JNJ
Johnson & Johnson
|
151.27 | 0% | 0% | 364.058,36 | 3,21% | 2,71% |
|
NYSE:MRK
Merck
|
130.99 | -9,88% | 3,33% | 331.772,3 | 2,35% | -19,03% |
|
LSE:AZN
AstraZeneca PLC
|
120.96 | 19,03% | 41,77% | 187.516,43 | 2,01% | 15,98% |
|
NYSE:PFE
Pfizer
|
28.53 | 8,9% | 39,33% | 161.667,9 | 5,87% | -9,31% |
|
ENXTPA:SAN
Sanofi
|
89.16 | 19,34% | 38,31% | 111.460,42 | 4,22% | 8,19% |
|
LSE:GSK
GSK
|
17.75 | 7,44% | 23,26% | 72.385,16 | 3,27% | 0,79% |
|
NasdaqGS:MRNA
Moderna
|
141.01 | -.110,1% | -.106,97% | 54.040,63 | 0% | 0% |
|
SWX:LONN
Lonza Group
|
529.20 | -28,51% | -13,46% | 38.164,1 | 0,76% | 0,68% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4165.00 | 0% | 0% | 6.534.609,49 | 4,75% | 0% |
|
NasdaqGS:NVAX
Novavax
|
14.79 | 0% | 0% | 623,13 | 0% | 0% |
|
NasdaqGM:CVAC
CureVac N.V.
|
3.40 | 0% | 0% | 564,45 | 0% | 0% |
|
ENXTPA:VLA
Valneva
|
3.95 | 0% | 0% | 474,1 | 0% | 0% |
|
NasdaqCM:VBIV
VBI Vaccines
|
0.64 | 0% | 0% | 18,27 | 0% | 0% |
